Prototype bird flu vax by April

NIBSC says a deletion H5N1 virus for vaccine will be ready for manufacturers in a month

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A deletion virus vaccine for H5N1 avian flu, created by reverse genetics, will be ready to go to “any manufacturer that wants it” by mid-April, John Wood of the UK's National Institute for Biological Standards and Control (NIBSC) has told The Scientist.

H5N1 has attacked eight Asian countries and killed 100 million birds, and is “historically unprecedented” as an epidemic of this kind, Anarfi Asamoa-Baah, World Health Organization (WHO) Assistant Director-General for Communicable Diseases, said on Tuesday (March 16).

According to WHO figures, by March 10 there had been 22 confirmed deaths in humans, all in Thailand and Vietnam, but the organization continues to fear the virus may mutate into a more virulent form.

Addressing a conference in Geneva on preparedness for the next influenza pandemic, Asamoa-Baah warned that WHO was already aware of reports “that H5N1 is causing disease and death in an unusual range of mammalian species.”

“Of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform